Literature DB >> 3396621

Acetylator polymorphism in discoid lupus erythematosus.

J M Ladero1, L C Jiménez, M J Fernández, A Robledo.   

Abstract

Acetylator phenotype was determined, using sulphamethazine, in 37 patients with histologically confirmed discoid lupus erythematosus, who were free from visceral damage, and in 157 normal control subjects. Twenty patients (54%) and 90 control subjects (57.4%) were slow acetylators (p not significant). Acetylator polymorphism appears not to be related to the risk of developing pure cutaneous discoid lupus erythematosus.

Entities:  

Mesh：

Year:  1988        PMID： 3396621     DOI： 10.1007/bf00540961

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


  21 in total

1.  Isoniazid and ethionamide serum levels and inactivation in Finnish subjects.

Authors:  H Tiitinen
Journal:  Scand J Respir Dis       Date:  1969

2.  Slow acetylation phenotype in systemic lupus erythematosus.

Authors:  E Fishbein; D Alarcón-Segovia
Journal:  Arthritis Rheum       Date:  1979-01

3.  Distribution of acetylator phenotype in relation to age and sex in Swedish patients. A retrospective study.

Authors:  O Paulsen; L G Nilsson
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  The acetylator phenotype of patients with systemic lupus erythematosus.

Authors:  M M Reidenberg; J H Martin
Journal:  Drug Metab Dispos       Date:  1974 Jan-Feb       Impact factor: 3.922

5.  Hepatic acetylator phenotype in bladder cancer patients.

Authors:  J M Ladero; C K Kwok; C Jara; L Fernandez; A M Silmi; D Tapia; A C Uson
Journal:  Ann Clin Res       Date:  1985

6.  Acetylator phenotype in idiopathic systemic lupus erythematosus.

Authors:  M M Reidenberg; M Levy; D E Drayer; E Zylber-Katz; W C Robbins
Journal:  Arthritis Rheum       Date:  1980-05

Review 7.  Genetically determined variability in acetylation and oxidation. Therapeutic implications.

Authors:  D W Clark
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

8.  Further evidence for the lack of association between acetylator phenotype and systemic lupus erythematosus.

Authors:  A N Baer; R L Woosley; T Pincus
Journal:  Arthritis Rheum       Date:  1986-04

9.  Acetylator phenotype and metabolic disposition of isoniazid in Japanese patients with systemic lupus erythematosus.

Authors:  T Ishizaki; Y Horai; G Koya; K Matsuyama; S Iguchi
Journal:  Arthritis Rheum       Date:  1981-10

10.  Normal distribution of acetylation phenotypes in systemic lupus erythematosus.

Authors:  J Vansant; R L Woosley; J T John; J S Sergent
Journal:  Arthritis Rheum       Date:  1978-03
View more
  2 in total

1.  N-acetylation phenotyping using dapsone in a Jordanian population.

Authors:  Y M Irshaid; H F al-Hadidi; M A Abuirjeie; N M Rawashdeh
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

2.  Acetylator phenotypes of Jordanian diabetics.

Authors:  Y Irshaid; H al-Hadidi; M Abuirjeie; A Latif; O Sartawi; N Rawashdeh
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.